Table of Contents
Leukemia Research and Treatment
Volume 2012 (2012), Article ID 876153, 14 pages
http://dx.doi.org/10.1155/2012/876153
Review Article

Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2

1Department of Oncology and Surgical Sciences, The University of Padova, 35128 Padova, Italy
2Department of Life and Reproduction Sciences, University of Verona, 37134 Verona, Italy

Received 9 September 2011; Accepted 24 September 2011

Academic Editor: Mineki Saito

Copyright © 2012 Francesca Rende et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lairmore and G. Franchini, “Human T-cell leukemia virus types 1 and 2,” in Fields Virology, D. M. Knipe and P. M. Howley, Eds., vol. 2, pp. 2071–2106, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 5th edition, 2007. View at Google Scholar
  2. B. K. Felber, H. Paskalis, and C. Kleinman-Ewing, “The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats,” Science, vol. 229, no. 4714, pp. 675–679, 1985. View at Google Scholar · View at Scopus
  3. V. Ciminale, D. M. D'Agostino, L. Zotti, G. Franchini, B. K. Felber, and L. Chieco- Bianchi, “Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II,” Virology, vol. 209, no. 2, pp. 445–456, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. H. Biswas, Z. Kaidarova, G. Garratty et al., “Increased all-cause and cancer mortality in HTLV-II infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 3, pp. 290–296, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. G. Feuer and P. L. Green, “Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2,” Oncogene, vol. 24, no. 39, pp. 5996–6004, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. N. Kwaan, T. H. Lee, D. M. Chafets et al., “Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data,” Journal of Infectious Diseases, vol. 194, no. 11, pp. 1557–1564, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. I. Cavallari, F. Rende, D. M. D'Agostino, and V. Ciminale, “Converging strategies in expression of human complex retroviruses,” Viruses, vol. 3, no. 8, pp. 1395–1414, 2011. View at Publisher · View at Google Scholar · View at PubMed
  8. M. T. Bartman, Z. Kaidarova, D. Hirschkorn et al., “Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection,” Blood, vol. 112, no. 10, pp. 3995–4002, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. Casoli, E. Pilotti, and U. Bertazzoni, “Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression,” AIDS Reviews, vol. 9, no. 3, pp. 140–149, 2007. View at Google Scholar · View at Scopus
  10. V. Ciminale, G. N. Pavlakis, D. Derse, C. P. Cunningham, and B. K. Felber, “Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I,” Journal of Virology, vol. 66, no. 3, pp. 1737–1745, 1992. View at Google Scholar · View at Scopus
  11. I. J. Koralnik, A. Gessain, M. E. Klotman, A. Lo Monico, Z. N. Berneman, and G. Franchini, “Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 18, pp. 8813–8817, 1992. View at Google Scholar · View at Scopus
  12. G. Gaudray, F. Gachon, J. Basbous, M. Biard-Piechaczyk, C. Devaux, and J. M. Mesnard, “The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription,” Journal of Virology, vol. 76, no. 24, pp. 12813–12822, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Halin, E. Douceron, I. Clerc et al., “Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription,” Blood, vol. 114, no. 12, pp. 2427–2438, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. Hidaka, J. Inoue, M. Yoshida, and M. Seiki, “Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins,” EMBO Journal, vol. 7, no. 2, pp. 519–523, 1988. View at Google Scholar · View at Scopus
  15. J. I. Inoue, M. Seiki, and M. Yoshida, “The second pX product p27x-III of HTLV-1 is required for gag gene expression,” FEBS Letters, vol. 209, no. 2, pp. 187–190, 1986. View at Google Scholar · View at Scopus
  16. F. Rende, I. Cavallari, A. Corradin et al., “Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs,” Blood, vol. 117, no. 18, pp. 4855–4859, 2011. View at Publisher · View at Google Scholar · View at PubMed
  17. A. Corradin, B. Di Camillo, V. Ciminale, G. Toffolo, and C. Cobelli, “Sensitivity analysis of retrovirus HTLV-1 transactivation,” Journal of Computational Biology, vol. 18, no. 2, pp. 183–193, 2011. View at Publisher · View at Google Scholar · View at PubMed
  18. S. Landry, M. Halin, S. Lefort et al., “Detection, characterization and regulation of antisense transcripts in HIV-1,” Retrovirology, vol. 4, article 71, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. M. Yoshida, Y. Satou, J. I. Yasunaga, J. I. Fujisawa, and M. Matsuoka, “Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene,” Journal of Virology, vol. 82, no. 19, pp. 9359–9368, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. J. M. Peloponese, T. Kinjo, and K. T. Jeang, “Human T-cell leukemia virus type 1 tax and cellular transformation,” International Journal of Hematology, vol. 86, no. 2, pp. 101–106, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. K. Chlichlia and K. Khazaie, “HTLV-1 Tax: linking transformation, DNA damage and apoptotic T-cell death,” Chemico-Biological Interactions, vol. 188, no. 2, pp. 359–365, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. Boxus, J. C. Twizere, S. Legros, J. F. Dewulf, R. Kettmann, and L. Willems, “The HTLV-1 Tax interactome,” Retrovirology, vol. 5, article 76, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. C. Journo, E. Douceron, and R. Mahieux, “HTLV gene regulation: because size matters, transcription is not enough,” Future Microbiology, vol. 4, no. 4, pp. 425–440, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. Higuchi and M. Fujii, “Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis,” Retrovirology, vol. 6, article 117, 2009. View at Publisher · View at Google Scholar · View at PubMed
  25. U. Bertazzoni, M. Turci, F. Avesani, G. di Gianfranco, C. Bidoia, and M. G. Romanelli, “Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 tax proteins: similarities and functional differences,” Viruses, vol. 3, no. 5, pp. 541–560, 2011. View at Publisher · View at Google Scholar · View at PubMed
  26. N. Sheehy, L. Lillis, K. Watters, M. Lewis, V. Gautier, and W. Hall, “Functional analysis of human T lymphotropic virus type 2 Tax proteins,” Retrovirology, vol. 3, article 20, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. T. M. Ross, A. C. Minella, Z. Y. Fang, S. M. Pettiford, and P. L. Green, “Mutational analysis of human T-cell leukemia virus type 2 Tax,” Journal of Virology, vol. 71, no. 11, pp. 8912–8917, 1997. View at Google Scholar · View at Scopus
  28. J. Basbous, A. Bazarbachi, C. Granier, C. Devaux, and J. M. Mesnard, “The central region of human T-cell leukemia virus type 1 tax protein contains distinct domains involved in subunit dimerization,” Journal of Virology, vol. 77, no. 24, pp. 13028–13035, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Y. Jin and K. T. Jeang, “HTLV-I Tax self-association in optimal trans-activation function,” Nucleic Acids Research, vol. 25, no. 2, pp. 379–387, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Shoji, M. Higuchi, R. Kondo et al., “Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2,” Retrovirology, vol. 6, article 1742, p. 83, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. M. Higuchi, C. Tsubata, R. Kondo et al., “Cooperation of NF-κB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line,” Journal of Virology, vol. 81, no. 21, pp. 11900–11907, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. G. Xiao, M. E. Cvijic, A. Fong et al., “Retroviral oncoprotein tax induces processing of NF-κB2/p100 in T cells: evidence for the involvement of IKKα,” EMBO Journal, vol. 20, no. 23, pp. 6805–6815, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. O. J. Semmes and K. T. Jeang, “Localization of human T-cell leukemia virus type 1 Tax to subnuclear compartments that overlap with interchromatin speckles,” Journal of Virology, vol. 70, no. 9, pp. 6347–6357, 1996. View at Google Scholar · View at Scopus
  34. L. Meertens, S. Chevalier, R. Weil, A. Gessain, and R. Mahieux, “A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 Tax protein sequences is responsible for their divergent subcellular distribution,” Journal of Biological Chemistry, vol. 279, no. 41, pp. 43307–43320, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. S. D. Gitlin, P. F. Lindholm, S. J. Marriott, and J. N. Brady, “Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus,” Journal of Virology, vol. 65, no. 5, pp. 2612–2621, 1991. View at Google Scholar · View at Scopus
  36. M. R. Smith and W. C. Greene, “Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein,” Virology, vol. 187, no. 1, pp. 316–320, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Turci, M. G. Romanelli, P. Lorenzi, P. Righi, and U. Bertazzoni, “Localization of human T-cell lymphotropic virus type II Tax protein is dependent upon a nuclear localization determinant in the N-terminal region,” Gene, vol. 365, no. 1-2, pp. 119–124, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. F. Bex, A. McDowall, A. Burny, and R. Gaynor, “The human T-cell leukemia virus type 1 transactivator protein tax colocalizes in unique nuclear structures with NB-κB proteins,” Journal of Virology, vol. 71, no. 5, pp. 3484–3497, 1997. View at Google Scholar · View at Scopus
  39. T. Alefantis, K. Mostoller, P. Jain, E. Harhaj, C. Grant, and B. Wigdahl, “Secretion of the human T cell leukemia virus type I transactivator protein tax,” Journal of Biological Chemistry, vol. 280, no. 17, pp. 17353–17362, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. T. Igakura, J. C. Stinchcombe, P. K. C. Goon et al., “Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton,” Science, vol. 299, no. 5613, pp. 1713–1716, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. M. Nejmeddine, V. S. Negi, S. Mukherjee et al., “HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse,” Blood, vol. 114, no. 5, pp. 1016–1025, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. Y. Kfoury, R. Nasr, A. Favre-Bonvin et al., “Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome,” Oncogene, vol. 27, no. 12, pp. 1665–1676, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. R. Nasr, E. Chiari, M. El-Sabban et al., “Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-κB activation,” Blood, vol. 107, no. 10, pp. 4021–4029, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. Y. Kfoury, N. Setterblad, M. El-Sabban et al., “Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome,” Blood, vol. 117, no. 1, pp. 190–199, 2011. View at Publisher · View at Google Scholar · View at PubMed
  45. F. Avesani, M. G. Romanelli, M. Turci et al., “Association of HTLV Tax proteins with TAK1-binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-κB activation,” Virology, vol. 408, no. 1, pp. 39–48, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. T. M. Ross, S. M. Pettiford, and P. L. Green, “The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes,” Journal of Virology, vol. 70, no. 8, pp. 5194–5202, 1996. View at Google Scholar · View at Scopus
  47. M. D. Robek and L. Ratner, “Immortalization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone,” Journal of Virology, vol. 73, no. 6, pp. 4856–4865, 1999. View at Google Scholar · View at Scopus
  48. H. Hasegawa, H. Sawa, M. J. Lewis et al., “Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I,” Nature Medicine, vol. 12, no. 4, pp. 466–472, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. M. Maruyama, H. Shibuya, H. Harada et al., “Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40(x) and T3/Ti complex triggering,” Cell, vol. 48, no. 2, pp. 343–350, 1987. View at Google Scholar · View at Scopus
  50. A. Niinuma, M. Higuchi, M. Takahashi et al., “Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus,” Journal of Virology, vol. 79, no. 18, pp. 11925–11934, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. M. Yoshida, “Multiple viral strategies of HTLV-1 for dysregulation of cell growth control,” Annual Review of Immunology, vol. 19, pp. 475–496, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. D. Saggioro, M. Silic-Benussi, R. Biasiotto, D. M. D'Agostino, and V. Ciminale, “Control of cell death pathways by HTLV-1 proteins,” Frontiers in Bioscience, vol. 14, pp. 3338–3351, 2009. View at Google Scholar · View at Scopus
  53. G. Tosi, E. Pilotti, L. Mortara, A. De Lerma Barbaro, C. Casoli, and R. S. Accolla, “Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 34, pp. 12861–12866, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. K. Endo, A. Hirata, K. Iwai et al., “Human T-cell leukemia virus type 2 (HTLV-2) tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax,” Journal of Virology, vol. 76, no. 6, pp. 2648–2653, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Mahieux, C. A. Pise-Masison, P. F. Lambert et al., “Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function,” Journal of Virology, vol. 74, no. 15, pp. 6866–6874, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. O. J. Semmes, F. Majone, C. Cantemir, L. Turchetto, B. Hjelle, and K. T. Jeang, “HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs,” Virology, vol. 217, no. 1, pp. 373–379, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. A. Tripp, Y. Liu, M. Sieburg, J. Montalbano, S. Wrzesinski, and G. Feuer, “Human T-cell leukemia virus type 1 Tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro,” Journal of Virology, vol. 77, no. 22, pp. 12152–12164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Tripp, P. Banerjee, M. Sieburg, V. Planelles, F. Li, and G. Feuer, “Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 tax in hematopoietic progenitor (CD34+) cells: modulation of p21 cip1/waf1 and p27kip1 expression,” Journal of Virology, vol. 79, no. 22, pp. 14069–14078, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. V. Ciminale, L. Zotti, D. M. D'Agostino, and L. Chieco-Bianchi, “Inhibition of human T-cell leukemia virus type 2 rex function by truncated forms of rex encoded in alternatively spliced mRNAs,” Journal of Virology, vol. 71, no. 4, pp. 2810–2818, 1997. View at Google Scholar · View at Scopus
  60. M. Narayan, I. Younis, D. M. D'Agostino, and P. L. Green, “Functional domain structure of human T-Cell leukemia virus type 2 rex,” Journal of Virology, vol. 77, no. 23, pp. 12829–12840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Nosaka, H. Siomi, Y. Adachi et al., “Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 24, pp. 9798–9802, 1989. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Nosaka, Y. Miyazaki, T. Takamatsu et al., “The post-transcriptional regulator Rex of the human T-cell leukemia virus type I is present as nucleolar speckles in infected cells,” Experimental Cell Research, vol. 219, no. 1, pp. 122–129, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. D. Palmeri and M. H. Malim, “The human T-cell leukemia virus type 1 posttranscriptional trans- activator Rex contains a nuclear export signal,” Journal of Virology, vol. 70, no. 9, pp. 6442–6445, 1996. View at Google Scholar · View at Scopus
  64. M. Grone, E. Hoffmann, S. Berchtold, B. R. Cullen, and R. Grassmann, “A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo,” Virology, vol. 204, no. 1, pp. 144–152, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. A. C. Black, I. S. Y. Chen, S. Arrigo et al., “Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5' long terminal repeat,” Virology, vol. 181, no. 2, pp. 433–444, 1991. View at Publisher · View at Google Scholar · View at Scopus
  66. A. C. Black, C. T. Ruland, M. T. Yip et al., “Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure,” Journal of Virology, vol. 65, no. 12, pp. 6645–6653, 1991. View at Google Scholar · View at Scopus
  67. M. Ohta, H. Nyunoya, H. Tanaka, T. Okamoto, T. Akagi, and K. Shimotohno, “Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA,” Journal of Virology, vol. 62, no. 12, pp. 4445–4451, 1988. View at Google Scholar · View at Scopus
  68. A. Bar-Shira, A. Panet, and A. Honigman, “An RNA secondary structure juxtaposes two remote genetic signals for human T-cell leukemia virus type I RNA 3'-end processing,” Journal of Virology, vol. 65, no. 10, pp. 5165–5173, 1991. View at Google Scholar · View at Scopus
  69. Y. F. Ahmed, S. M. Hanly, M. H. Malim, B. R. Cullen, and W. C. Greene, “Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action,” Genes and Development, vol. 4, no. 6, pp. 1014–1022, 1990. View at Google Scholar · View at Scopus
  70. J. Ye, L. Silverman, M. D. Lairmore, and P. L. Green, “HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro,” Blood, vol. 102, no. 12, pp. 3963–3969, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. H. Siomi, H. Shida, S. H. Nam, T. Nosaka, M. Maki, and M. Hatanaka, “Sequence requirements for nucleolar localization of human T cell leukemia virus type 1 pX protein, which regulates viral RNA processing,” Cell, vol. 55, no. 2, pp. 197–209, 1988. View at Google Scholar · View at Scopus
  72. R. Grassmann, S. Berchtold, C. Aepinus, C. Ballaun, E. Boehnlein, and B. Fleckenstein, “In vitro binding of human T-cell leukemia virus rex proteins to the rex-response element of viral transcripts,” Journal of Virology, vol. 65, no. 7, pp. 3721–3727, 1991. View at Google Scholar · View at Scopus
  73. I. Weichselbraun, G. K. Farrington, J. R. Rusche, E. Bohnlein, and J. Hauber, “Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange,” Journal of Virology, vol. 66, no. 4, pp. 2583–2587, 1992. View at Google Scholar · View at Scopus
  74. F. J. Kim, A. A. Beeche, J. J. Hunter, D. J. Chin, and T. J. Hope, “Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions,” Molecular and Cellular Biology, vol. 16, no. 9, pp. 5147–5155, 1996. View at Google Scholar · View at Scopus
  75. H. P. Bogerd, R. A. Fridell, S. Madore, and B. R. Cullen, “Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins,” Cell, vol. 82, no. 3, pp. 485–494, 1995. View at Google Scholar · View at Scopus
  76. H. P. Bogerd, A. Echarri, T. M. Ross, and B. R. Cullen, “Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1,” Journal of Virology, vol. 72, no. 11, pp. 8627–8635, 1998. View at Google Scholar · View at Scopus
  77. H. Bogerd and W. C. Greene, “Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo,” Journal of Virology, vol. 67, no. 5, pp. 2496–2502, 1993. View at Google Scholar · View at Scopus
  78. L. Englmeier, M. Fornerod, F. R. Bischoff, C. Petosa, I. W. Mattaj, and U. Kutay, “RanBP3 influences interactions between CRM1 and its nuclear protein export substrates,” EMBO Reports, vol. 2, no. 10, pp. 926–932, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. Y. Hakata, T. Umemoto, S. Matsushita, and H. Shida, “Involvement of human CRM1 (Exportin 1) in the export and multimerization of the rex protein of human T-cell leukemia virus type,” Journal of Virology, vol. 72, no. 8, pp. 6602–6607, 1998. View at Google Scholar · View at Scopus
  80. J. Katahira, T. Ishizaki, H. Sakai, A. Adachi, K. Yamamoto, and H. Shida, “Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding,” Journal of Virology, vol. 69, no. 5, pp. 3125–3133, 1995. View at Google Scholar · View at Scopus
  81. Y. Hakata, M. Yamada, and H. Shida, “A multifunctional domain in human CRM1 (Exportin 1) mediates RanBP3 binding and multimerization of human T-cell leukemia virus type 1 Rex protein,” Molecular and Cellular Biology, vol. 23, no. 23, pp. 8751–8761, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. T. R. Reddy, W. D. Xu, and F. Wong-Staal, “General effect of Sam68 on Rev/Rex regulated expression of complex retroviruses,” Oncogene, vol. 19, no. 35, pp. 4071–4074, 2000. View at Google Scholar · View at Scopus
  83. K. L. McGuire, V. E. Curtiss, E. L. Larson, and W. A. Haseltine, “Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression,” Journal of Virology, vol. 67, no. 3, pp. 1590–1599, 1993. View at Google Scholar · View at Scopus
  84. H. Kanamori, N. Suzuki, H. Siomi et al., “HTLV-1 p27(rex) stabilizes human interleukin-2 receptor α chain mRNA,” EMBO Journal, vol. 9, no. 12, pp. 4161–4166, 1990. View at Google Scholar · View at Scopus
  85. R. Weil, J. P. Levraud, M. Duc Dodon et al., “Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines,” Journal of Virology, vol. 73, no. 5, pp. 3709–3717, 1999. View at Google Scholar · View at Scopus
  86. M. P. Cooke, K. M. Abraham, K. A. Forbush, and R. M. Perlmutter, “Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59(fyn)),” Cell, vol. 65, no. 2, pp. 281–291, 1991. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Valentin, S. Hamaia, S. König, and L. Gazzolo, “Vascular cell adhesion molecule-1 induced by human T-cell leukemia virus type 1 Tax protein in T-cells stimulates proliferation of human T-lymphocytes,” Journal of General Virology, vol. 82, no. 4, pp. 831–835, 2001. View at Google Scholar
  88. M. Abe, H. Suzuki, H. Nishitsuji, H. Shida, and H. Takaku, “Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing,” FEBS Letters, vol. 584, no. 20, pp. 4313–4318, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. M. D. Dodon, S. Hamaia, J. Martin, and L. Gazzolo, “Heterogeneous nuclear ribonucleoprotein A1 interferes with the binding of the human T cell leukemia virus type 1 Rex regulatory protein to its response element,” Journal of Biological Chemistry, vol. 277, no. 21, pp. 18744–18752, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. E. Kress, H. H. Baydoun, F. Bex, L. Gazzolo, and M. D. Dodon, “Critical role of hnRNP A1 in HTLV-1 replication in human transformed T lymphocytes,” Retrovirology, vol. 2, p. 8, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. A. C. Black, C. T. Ruland, J. Luo, A. Bakker, J. K. Fraser, and J. D. Rosenblatt, “Binding of nuclear proteins to HTLV-II cis-acting repressive sequence (CRS) RNA correlates with CRS function,” Virology, vol. 200, no. 1, pp. 29–41, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. M. Itoh, J. I. Inoue, H. Toyoshima, T. Akizawa, M. Higashi, and M. Yoshida, “HTLV-1 rex and HIV-1 rev act through similar mechanisms to relieve suppression of unspliced RNA expression,” Oncogene, vol. 4, no. 11, pp. 1275–1279, 1989. View at Google Scholar · View at Scopus
  93. M. Seiki, A. Hikikoshi, and M. Yoshida, “The U5 sequence is a cis-acting repressive element for genomic RNA expression of human T cell leukemia virus type I,” Virology, vol. 176, no. 1, pp. 81–86, 1990. View at Publisher · View at Google Scholar · View at Scopus
  94. J. A. King, J. M. Bridger, M. Löchelt et al., “Nucleocytoplasmic transport of HTLV-1 RNA is regulated by two independent LTR encoded nuclear retention elements,” Oncogene, vol. 16, no. 25, pp. 3309–3316, 1998. View at Google Scholar · View at Scopus
  95. C. Ballaun, G. K. Farrington, M. Dobrovnik, J. Rusche, J. Hauber, and E. Bohnlein, “Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of rex protein correlates with in vivo activity,” Journal of Virology, vol. 65, no. 8, pp. 4408–4413, 1991. View at Google Scholar · View at Scopus
  96. T. Unge, L. Solomin, M. Mellini, D. Derse, B. K. Felber, and G. N. Pavlakis, “The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 16, pp. 7145–7149, 1991. View at Google Scholar · View at Scopus
  97. H. P. Bogerd, G. L. Huckaby, Y. F. Ahmed, S. M. Hanly, and W. C. Greene, “The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 13, pp. 5704–5708, 1991. View at Publisher · View at Google Scholar · View at Scopus
  98. D. M. D'Agostino, V. Ciminale, L. Zotti, and L. Chieco-Bianchi, “Influence of Rex and intronic sequences on expression of spliced mRNAs produced by human T cell leukemia virus type I,” AIDS Research and Human Retroviruses, vol. 15, no. 15, pp. 1351–1363, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. A. Saiga, S. Orita, N. Minoura-Tada et al., “Cis-Acting inhibitory elements within the pol-env region of human T- cell leukemia virus type 1 possibly involved in viral persistence,” Journal of Virology, vol. 71, no. 6, pp. 4485–4494, 1997. View at Google Scholar · View at Scopus
  100. P. Heger, O. Rosorius, J. Hauber, and R. H. Stauber, “Titration of cellular export factors, but not heteromultimerization, is the molecular mechanism of trans-dominant HTLV-1 Rex mutants,” Oncogene, vol. 18, no. 28, pp. 4080–4090, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. S. Kubota, M. Hatanaka, and R. J. Pomerantz, “Nucleo-cytoplasmic redistribution of the HTLV-I rex protein: alterations by coexpression of the HTLV-I p21x protein,” Virology, vol. 220, no. 2, pp. 502–507, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. V. W. Valeri, A. Hryniewicz, V. Andresen et al., “Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits,” Blood, vol. 116, no. 19, pp. 3809–3817, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. L. R. Silverman, A. J. Phipps, A. Montgomery, L. Ratner, and M. D. Lairmore, “Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion,” Journal of Virology, vol. 78, no. 8, pp. 3837–3845, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. B. Yamamoto, M. Li, M. Kesic, I. Younis, M. D. Lairmore, and P. L. Green, “Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo,” Retrovirology, vol. 5, article 38, 2008. View at Publisher · View at Google Scholar · View at PubMed
  105. C. Nicot, M. Dundr, J. M. Johnson et al., “HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication,” Nature Medicine, vol. 10, no. 2, pp. 197–201, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. I. Younis, L. Khair, M. Dundr, M. D. Lairmore, G. Franchini, and P. L. Green, “Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator,” Journal of Virology, vol. 78, no. 20, pp. 11077–11083, 2004. View at Publisher · View at Google Scholar · View at PubMed
  107. W. Zhang, J. W. Nisbet, J. T. Bartoe, W. Ding, and M. D. Lairmore, “Human T-lymphotropic virus type 1 p30II functions as a transcription factor and differentially modulates CREB-responsive promoters,” Journal of Virology, vol. 74, no. 23, pp. 11270–11277, 2000. View at Publisher · View at Google Scholar · View at Scopus
  108. W. Zhang, J. W. Nisbet, B. Albrecht et al., “Human T-lymphotropic virus type 1 p30II regulates gene transcription by binding CREB binding protein/p300,” Journal of Virology, vol. 75, no. 20, pp. 9885–9895, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. B. Michael, A. M. Nair, H. Hiraragi et al., “Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes,” Retrovirology, vol. 1, p. 39, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. J. M. Taylor, S. Ghorbel, and C. Nicot, “Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30,” BMC Genomics, vol. 10, article 311, 2009. View at Publisher · View at Google Scholar · View at PubMed
  111. U. Sinha-Datta, A. Datta, S. Ghorbel, M. D. Dodon, and C. Nicot, “Human T-cell lymphotrophic virus type I Rex and p30 interactions govern the switch between virus latency and replication,” Journal of Biological Chemistry, vol. 282, no. 19, pp. 14608–14615, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. X. T. Bai, H. H. Baydoun, and C. Nicot, “HTLV-I p30: a versatile protein modulating virus replication and pathogenesis,” Molecular Aspects of Medicine, vol. 31, no. 5, pp. 344–349, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  113. A. Datta, U. Sinha-Datta, N. K. Dhillon, S. Buch, and C. Nicot, “The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages,” Journal of Biological Chemistry, vol. 281, no. 33, pp. 23414–23424, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. V. Ciminale, L. Zotti, D. M. D'Agostino et al., “Mitochondrial targeting of the p13(II) protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I),” Oncogene, vol. 18, no. 31, pp. 4505–4514, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  115. M. Silic-Benussi, I. Cavallari, N. Vajente et al., “Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells,” Blood, vol. 116, no. 1, pp. 54–62, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. V. Andresen, C. A. Pise-Masison, U. Sinha-Datta et al., “Suppression of HTLV-1 replication by tax-mediated rerouting of the p13 viral protein to nuclear speckles,” Blood, vol. 118, no. 6, pp. 1549–1559, 2011. View at Publisher · View at Google Scholar · View at PubMed
  117. M. Silic-Benussi, E. Cannizzaro, A. Venerando et al., “Modulation of mitochondrial K+ permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1,” Biochimica et Biophysica Acta, vol. 1787, no. 7, pp. 947–954, 2009. View at Publisher · View at Google Scholar · View at PubMed
  118. M. Silic-Benussi, R. Biasiotto, V. Andresen, G. Franchini, D. M. D'Agostino, and V. Ciminale, “HTLV-1 p13, a small protein with a busy agenda,” Molecular Aspects of Medicine, vol. 31, no. 5, pp. 350–358, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. D. M. D'Agostino, P. Bernardi, L. Chieco-Bianchi, and V. Ciminale, “Mitochondria as functional targets of proteins coded by human tumor viruses,” Advances in Cancer Research, vol. 94, no. 1, pp. 87–142, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. M. Silic-Benussi, I. Cavallari, T. Zorzan et al., “Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6629–6634, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  121. H. Hiraragi, B. Michael, A. Nair, M. Silic-Benussi, V. Ciminale, and M. Lairmore, “Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13 II sensitizes Jurkat T cells to Ras-mediated apoptosis,” Journal of Virology, vol. 79, no. 15, pp. 9449–9457, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. J. C. Mulloy, R. W. Crowley, J. Fullen, W. J. Leonard, and G. Franchini, “The human T-cell leukemia/lymphotropic virus type 1 p12 protein binds the interleukin-2 receptor β and γc chains and affects their expression on the cell surface,” Journal of Virology, vol. 70, no. 6, pp. 3599–3605, 1996. View at Google Scholar
  123. C. Nicot, J. C. Mulloy, M. G. Ferrari et al., “HTLV-1 p12I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells,” Blood, vol. 98, no. 3, pp. 823–829, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. J. M. Johnson, C. Nicot, J. Fullen et al., “Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12I protein,” Journal of Virology, vol. 75, no. 13, pp. 6086–6094, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  125. W. Ding, B. Albrecht, R. Luo et al., “Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12I: association with calreticulin and calnexin,” Journal of Virology, vol. 75, no. 16, pp. 7672–7682, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. W. Ding, B. Albrecht, R. E. Kelley et al., “Human T-cell lymphotropic virus type 1 p12I expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells,” Journal of Virology, vol. 76, no. 20, pp. 10374–10382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  127. C. Nicot, R. L. Harrod, V. Ciminale, and G. Franchini, “Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions,” Oncogene, vol. 24, no. 39, pp. 6026–6034, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  128. B. Albrecht, C. D. D'Souza, W. Ding, S. Tridandapani, K. M. Coggeshall, and M. D. Lairmore, “Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12I,” Journal of Virology, vol. 76, no. 7, pp. 3493–3501, 2002. View at Publisher · View at Google Scholar · View at Scopus
  129. S. J. Kim, W. Ding, B. Albrecht, P. L. Green, and M. D. Lairmore, “A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation,” Journal of Biological Chemistry, vol. 278, no. 18, pp. 15550–15557, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. N. Van Prooyen, V. Andresen, H. Gold, I. Bialuk, C. Pise-Masison, and G. Franchini, “Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins,” Molecular Aspects of Medicine, vol. 31, no. 5, pp. 333–343, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. N. Van Prooyen, H. Gold, V. Andresen et al., “Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 48, pp. 20738–20743, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  132. J. M. Johnson, J. C. Mulloy, V. Ciminale, J. Fullen, C. Nicot, and G. Franchini, “The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2,” AIDS Research and Human Retroviruses, vol. 16, no. 16, pp. 1777–1781, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. D. Larocca, L. A. Chao, M. H. Seto, and T. K. Brunck, “Human T-cell leukemia virus minus strand transcription in infected T-cells,” Biochemical and Biophysical Research Communications, vol. 163, no. 2, pp. 1006–1013, 1989. View at Google Scholar
  134. M. H. Cavanagh, S. Landry, B. Audet et al., “HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated,” Retrovirology, vol. 3, article 15, 2006. View at Publisher · View at Google Scholar · View at PubMed
  135. K. Murata, T. Hayashibara, K. Sugahara et al., “A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization,” Journal of Virology, vol. 80, no. 5, pp. 2495–2505, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. Y. Satou, J. I. Yasunaga, M. Yoshida, and M. Matsuoka, “HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 720–725, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  137. T. Usui, K. Yanagihara, K. Tsukasaki et al., “Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells,” Retrovirology, vol. 5, article 34, 2008. View at Publisher · View at Google Scholar · View at PubMed
  138. S. Landry, M. Halin, A. Vargas, I. Lemasson, J. M. Mesnard, and B. Barbeau, “Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein,” Journal of Virology, vol. 83, no. 4, pp. 2048–2054, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. P. Hivin, M. Frédéric, C. Arpin-André et al., “Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs,” Journal of Cell Science, vol. 118, no. 7, pp. 1355–1362, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. P. Hivin, J. Basbous, F. Raymond et al., “The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies,” Retrovirology, vol. 4, article 14, 2007. View at Publisher · View at Google Scholar · View at PubMed
  141. J. Arnold, B. Yamamoto, M. Li et al., “Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1,” Blood, vol. 107, no. 10, pp. 3976–3982, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. Y. Satou, J.-I. Yasunaga, T. Zhao et al., “HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo,” PLoS Pathogens, vol. 7, no. 2, article e1001274, 2011. View at Publisher · View at Google Scholar · View at PubMed
  143. I. Clerc, N. Polakowski, C. André-Arpin et al., “An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ,” Journal of Biological Chemistry, vol. 283, no. 35, pp. 23903–23913, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. T. Zhao, Y. Satou, K. Sugata et al., “HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator,” Blood, vol. 118, no. 7, pp. 1865–1876, 2011. View at Publisher · View at Google Scholar · View at PubMed
  145. J. Basbous, C. Arpin, G. Gaudray, M. Piechaczyk, C. Devaux, and J. M. Mesnard, “The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity,” Journal of Biological Chemistry, vol. 278, no. 44, pp. 43620–43627, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  146. S. Thébault, J. Basbous, P. Hivin, C. Devaux, and J. M. Mesnard, “HBZ interacts with JunD and stimulates its transcriptional activity,” FEBS Letters, vol. 562, no. 1–3, pp. 165–170, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. J. Matsumoto, T. Ohshima, O. Isono, and K. Shimotohno, “HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein,” Oncogene, vol. 24, no. 6, pp. 1001–1010, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. A. S. Kuhlmann, J. Villaudy, L. Gazzolo, M. Castellazzi, J. M. Mesnard, and M. D. Dodon, “HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT),” Retrovirology, vol. 4, article 92, 2007. View at Publisher · View at Google Scholar · View at PubMed
  149. R. Mukai and T. Ohshima, “Dual effects of HTLV-1 bZIP factor in suppression of interferon regulatory factor 1,” Biochemical and Biophysical Research Communications, vol. 409, no. 2, pp. 328–332, 2011. View at Publisher · View at Google Scholar · View at PubMed
  150. T. Zhao, J. I. Yasunaga, Y. Satou et al., “Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-κB,” Blood, vol. 113, no. 12, pp. 2755–2764, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. H. Zhi, L. Yang, Y.-L. Kuo, Y.-K. Ho, H.-M. Shih, and C.-Z. Giam, “NF-κB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ,” PLoS Pathogens, vol. 7, no. 4, 2011. View at Publisher · View at Google Scholar · View at PubMed
  152. J. Arnold, B. Zimmerman, M. Li, M. D. Lairmore, and P. L. Green, “Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation,” Blood, vol. 112, no. 9, pp. 3788–3797, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. G. Choudhary and L. Ratner, “The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30 II mRNA,” Virology, vol. 410, no. 2, pp. 307–315, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus